Palopag 200200mg
Tablet
Incepta Pharmaceuticals Ltd.
Additional Offers
Show allIndication
Pulmonary Arterial Hypertension
Administration
Swallow tablet whole; do not split, crush, or chew Tolerability may be improved when taken with food Dose interruptions and discontinuations ... View More
Adult Dose
Pulmonary Arterial Hypertension Indicated for pulmonary arterial hypertension (PAH, WHO Group I) to delay disease progression and reduce the risk of ho... View More
Renal Dose
Renal impairment: No dosage adjustment required
Contraindication
Concomitant use of strong CYP2C8 inhibitors (eg, gemfibrozil)
Mode of Action
Selectively activates the prostacyclin receptor (ie, IP-receptor), one of 5 types of prostanoid receptors Unlike prostacyclin analogs, selexipag is sel... View More
Precaution
If signs of pulmonary edema occur, consider the possibility of associated pulmonary veno-occlusive disease (PVOD); if PVOD is confirmed, discontinue sel... View More
Side Effect
>10% Headache (65%) Diarrhea (42%) Jaw pain (26%) Nausea (33%) Vomiting (18%) Pain in extremity (17%) Myalgia (16%) Flushing (12%) Arthralgia (... View More
Interaction
Coadministration with strong CYP2C8 inhibitors may result in a significant increase in exposure to selexipag and its active metabolite Avoid co... View More
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More